These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 24476439)

  • 1. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer.
    Saltz LB; Bach PB
    N Engl J Med; 2014 Jan; 370(5):478. PubMed ID: 24476439
    [No Abstract]   [Full Text] [Related]  

  • 2. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer.
    Von Hoff DD; Goldstein D; Renschler MF
    N Engl J Med; 2014 Jan; 370(5):479-80. PubMed ID: 24476438
    [No Abstract]   [Full Text] [Related]  

  • 3. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer.
    Sahoo RK; Kumar L
    N Engl J Med; 2014 Jan; 370(5):478-9. PubMed ID: 24476440
    [No Abstract]   [Full Text] [Related]  

  • 4. Pancreatic cancer: standing on the shoulders of mice, making an iMPACT on pancreatic cancer.
    Villanueva MT
    Nat Rev Clin Oncol; 2013 Dec; 10(12):665. PubMed ID: 24189469
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nab-paclitaxel use in pancreatic cancer: practical aspects and consequences in a French oncology day-care unit].
    Hubault M; Faure R; Walter T; Forestier J; Lombard-Bohas C; Pivot C
    Bull Cancer; 2015 May; 102(5):403-4. PubMed ID: 25866372
    [No Abstract]   [Full Text] [Related]  

  • 6. New option for the initial management of metastatic pancreatic cancer?
    Abbruzzese JL; Hess KR
    J Clin Oncol; 2014 Aug; 32(23):2405-7. PubMed ID: 24982449
    [No Abstract]   [Full Text] [Related]  

  • 7. A treatment landscape in evolution: new strategies, guidelines, and therapeutic advances for metastatic pancreatic adenocarcinoma.
    Bekaii-Saab T
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):5-7. PubMed ID: 30807560
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment Outcome of Nab-paclitaxel Plus Gemcitabine for Leptomeningeal Carcinomatosis from Pancreatic Ductal Adenocarcinoma: An Autopsy Case Report.
    Iwatsuka K; Kikuta D; Shibuya H; Ogawa M; Gotoda T; Moriyama M; Nakagawara H; Hemmi A; Yamao K
    Intern Med; 2021 Dec; 60(23):3743-3748. PubMed ID: 34148945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary management of pancreatic cancer.
    Tempero MA
    J Natl Compr Canc Netw; 2015 May; 13(5 Suppl):700-2. PubMed ID: 25995435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The winning formulation: the development of paclitaxel in pancreatic cancer.
    Ma WW; Hidalgo M
    Clin Cancer Res; 2013 Oct; 19(20):5572-9. PubMed ID: 23918602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U.S. Food and Drug Administration approves paclitaxel protein-bound particles (Abraxane®) in combination with gemcitabine as first-line treatment of patients with metastatic pancreatic cancer.
    Saif MW
    JOP; 2013 Nov; 14(6):686-8. PubMed ID: 24216565
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nab-Paclitaxel plus Gemcitabine for Patients with Recurrence after Resection for Adenocarcinoma of the Pancreas].
    Kawaida H; Hosomura N; Amemiya H; Higuchi Y; Tsukahara I; Nakayama T; Saito R; Shoda K; Nakata Y; Furuya S; Akaike H; Kawaguchi Y; Sudo M; Kono H; Ichikawa D
    Gan To Kagaku Ryoho; 2021 Jan; 48(1):107-109. PubMed ID: 33468736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Gemcitabine and Nab-Paclitaxel Misses the Target in Pancreas Adenocarcinoma: Or Did an Effective Therapy Fall to the Definition of Recurrence?
    Manji GA
    J Clin Oncol; 2023 Apr; 41(11):1972-1975. PubMed ID: 36854094
    [No Abstract]   [Full Text] [Related]  

  • 14. Paraspinal radiation recall myositis after gemcitabine for pancreatic adenocarcinoma.
    Barrios-Anderson A; Radhakrishnan R; Yu E; Shimanovsky A
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33947675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapeutic strategies in the second line setting of advanced or metastatic pancreatic adenocarcinoma.
    Ramfidis VS; Syrigos KN; Saif MW
    JOP; 2013 Jul; 14(4):344-6. PubMed ID: 23846924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Nab-paclitaxel combined with gemcitabine in neoadjuvant chemotherapy laparoscopic followed by pancreatoduodenectomy to a patient with pancreas head cancer invading to protal vein.
    Li C; Huang B; Yan Y; Yang X
    Asian J Surg; 2022 Nov; 45(11):2457-2459. PubMed ID: 35697626
    [No Abstract]   [Full Text] [Related]  

  • 17. Progressive digital necrosis during gemcitabine/nab-paclitaxel chemotherapy in a patient with pancreatic cancer.
    Shimizu Y; Ohata C
    Dermatol Ther; 2022 Apr; 35(4):e15353. PubMed ID: 35108430
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac Masses in a Patient With Pancreatic Adenocarcinoma and a History of Breast Carcinoma.
    Nunnery S; Bottinor W; Das S
    JAMA Oncol; 2020 Jun; 6(6):917-918. PubMed ID: 32324203
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas.
    Miwa H; Sugimori K; Ishii T; Funaoka A; Tsuchiya H; Suzuki Y; Sugimori M; Nishimura M; Tozuka Y; Komiyama S; Sato T; Kaneko T; Numata K; Maeda S
    Intern Med; 2021 Aug; 60(16):2607-2612. PubMed ID: 33642489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Adenocarcinoma Treated With Irreversible Electroporation Case Report: First Experience and Outcome.
    Trueba-Arguiñarena FJ; de Prado-Otero DS; Poves-Alvarez R
    Medicine (Baltimore); 2015 Jul; 94(26):e946. PubMed ID: 26131840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.